Free Trial

Anavex Life Sciences (AVXL) SEC Filings & 10K Form

$4.00
-0.17 (-4.08%)
(As of 05/24/2024 ET)

Recent Anavex Life Sciences SEC Filings

DateFilerForm TypeView
05/17/2024
5:01 AM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
7:00 AM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
5:01 AM
Anavex Life Sciences (Filer)
Form DEF 14A
05/06/2024
5:03 AM
Anavex Life Sciences (Filer)
Form DEFA14A
04/01/2024
5:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
7:34 AM
Anavex Life Sciences (Subject)
MISSLING CHRISTOPHER U (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/23/2024
5:03 AM
Anavex Life Sciences (Issuer)
Skarpelos Athanasios (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:03 AM
Anavex Life Sciences (Issuer)
Ma Jiong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:04 AM
Anavex Life Sciences (Issuer)
Velden Claus Vander (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:04 AM
Anavex Life Sciences (Issuer)
Thomas Steffen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
5:05 AM
Anavex Life Sciences (Issuer)
Donhauser Peter D.O. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
4:01 PM
Anavex Life Sciences (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/22/2024
10:34 AM
Anavex Life Sciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/12/2024
7:00 PM
Anavex Life Sciences (Issuer)
Boenisch Sandra (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2024
7:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2023
3:30 PM
Anavex Life Sciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
06/30/2023
7:00 PM
Anavex Life Sciences (Issuer)
MISSLING CHRISTOPHER U (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2023
11:11 AM
Anavex Life Sciences (Subject)
MISSLING CHRISTOPHER U (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2023
3:30 PM
Anavex Life Sciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:AVXL) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners